Tag Archives: ECYT

Best Performing Stocks To Own For 2018

Spanish banks have done alright over the past year, with BBVA (BBVA), Santander (SAN), and Caixa (OTCPK:CAIXY) all up between 20% and 30%, in line with other well-liked European banks like ING (ING), and well ahead of some of their other large European peers. Even with the turbulence in Catalonia, economic conditions have been improving in Spain, and with that so has credit quality. Whats more, both BBVA and Santander have gotten a little more proactive about selling underperforming assets.

While BBVA has done fine over the past year, there could still be a little upside left in the shares. Even though I dont think BBVA will get to the psychologically important 10% ROE level for a few years, I do expect double-digit earnings growth over the next five years and high single-digit growth over the long term, supporting a fair value around $9/ADR.

Spain Still Turbulent

While Spain remains a large portion of BBVAs loan book (around 45%) and risk-weighted assets (around one-third), it still only contributes less than 20% of earnings, as the bank (and the country) continues to dig itself out of a deep hole created by the property and mortgage collapse roughly a decade ago.

Best Performing Stocks To Own For 2018: Uni-Pixel, Inc.(UNXL)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Uni-Pixel (UNXL) manufactures electronic film products using its proprietary manufacturing process, UniBoss. This stock closed up 7.6% to $16.84 in Monday’s trading session.

    Monday’s Volume: 1.88 million

    Three-Month Average Volume: 1 million

    Volume % Change: 108%

    From a technical perspective, UNXL bounced sharply higher here right off its 50-day moving average of $15.89 with above-average volume. This stock looks to be forming a double bottom chart pattern at $14.91 to $15.16. If that bottom holds, then shares of UNXL could see a continuation of Monday’s upside action.

    Traders should now look for long-biased trades in UNXL as long as it’s trending above $15.16 or $14.91 and then once it sustains a move or close above Monday’s high of $17.53 with volume that hits near or above 1 million shares. If we get that move soon, then UNXL will set up to re-test or possibly take out its next major overhead resistance level at its 200-day moving average of $19.89.

  • [By Peter Graham]

    Small cap sensor film stock UniPixel Inc (NASDAQ: UNXL) is sinking by a double digit percentage in after-hours and pre-market trading after reporting Q4 earnings. The problem for UniPixel is that only a few analysts cover the small cap stock and the bottom line loss was a bit worst than the 10 cent loss they were expecting. The stock also had a slight uptick ahead of earnings:

  • [By Lisa Levin]

    Shares of UniPixel Inc (NASDAQ: UNXL) were down 22 percent to $1.63 after the company announced a public offering of newly issued shares of stock. UniPixel plans to offer 5.35 million shares of its own stock at a public offering price of $1.50 per share with the option for its underwriters to purchase up to an additional 802,500 shares.

  • [By Peter Graham]

    Small cap sensor film stockUniPixel Inc (NASDAQ: UNXL) reportedQ1 2017 earnings after the Thursday market close withshares falling both on Thursday and in afterhours trading. UniPixel is not well covered or known by analysts yet and this can make shares volatile. However and last September, we had suggested a long position in the stock based upon technicals by saying:

Best Performing Stocks To Own For 2018: Scana Corporation(SCG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares rose by just 0.1 percent. Meanwhile, top losers in the sector included Atlantic Power Corp (NYSE: AT), down 2 percent, and SCANA Corporation (NYSE: SCG) down 1 percent.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was SCANA Corp. (NYSE: SCG) which traded down over 6% at $42.38. The stocks 52-week range is $41.15 to $74.99. Volume was over 3.5 million versus the daily average of 2.2 million shares.

  • [By Lisa Levin]

    In trading on Monday, utilities shares were relative laggards, down on the day by about 0.43 percent. Meanwhile, top losers in the sector included SCANA Corporation (NYSE: SCG), down 2 percent, and FirstEnergy Corp. (NYSE: FE), down 2 percent.

Best Performing Stocks To Own For 2018: StoneMor Partners L.P.(STON)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Best Performing Stocks To Own For 2018: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

Best Medical Stocks To Own Right Now

President and CEO of Bluebird Bio Inc (NASDAQ:BLUE) Nick Leschly sold 117,500 shares of BLUE on 12/13/2017 at an average price of $184.08 a share. The total sale was $21.6 million.

bluebird bio Inc is a clinical-stage biotechnology company which develops gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy. bluebird bio Inc has a market cap of $8.38 billion; its shares were traded at around $182.95 with and P/S ratio of 233.32.

CEO Recent Trades:

President and CEO Nick Leschly sold 117,500 shares of BLUE stock on 12/13/2017 at the average price of $184.08. The price of the stock has decreased by 0.61% since.

Directors and Officers Recent Trades:

Director Mark Vachon sold 7,000 shares of BLUE stock on 12/11/2017 at the average price of $216.64. The price of the stock has decreased by 15.55% since.and Strategy Officer Jeffrey T. Walsh sold 9,900 shares of BLUE stock on 12/11/2017 at the average price of $216.54. The price of the stock has decreased by 15.51% since.COO Susanna Gatti High sold 1,282 shares of BLUE stock on 12/01/2017 at the average price of $172.15. The price of the stock has increased by 6.27% since.Chief Scientific Officer Philip D Gregory sold 2,250 shares of BLUE stock on 12/01/2017 at the average price of $172.54. The price of the stock has increased by 6.03% since.Chief Medical Officer David Davidson sold 4,000 shares of BLUE stock on 12/01/2017 at the average price of $172.42. The price of the stock has increased by 6.11% since.

For the complete insider trading history of BLUE, click here

Best Medical Stocks To Own Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

Best Medical Stocks To Own Right Now: CoreSite Realty Corporation(COR)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Denver, Colorado-based CoreSite Realty Corporation (COR) offers cloud-enabled, high-performance data center campuses.

    Operating across 17 data centers in eight key North American markets, CoreSite serves a broad range of clients, including telecommunications carriers, media companies, financial and educational institutions, and government agencies.

Best Medical Stocks To Own Right Now: LaSalle Hotel Properties(LHO)

Advisors’ Opinion:

  • [By Marshall Hargrave]

    The other key benefit for Strategic is that it enjoys industry-leading earnings before interest, taxes, depreciation and amortization (EBITDA) per available room. For 2012, Strategic generated $81 per room of EBITDA. Compare this to top comps LaSalle Hotel (NYSE: LHO) at $74 per room and Pebblebrook Hotel Trust (NYSE: PEB) at $71. The reason for this is that Strategic is much less reliant than its peers on rooms, with much greater exposure to food and beverages. Strategic earns 53% of its revenue from rooms, while its peers get around 66% of revenues from rooms.

Best Medical Stocks To Own Right Now: Devon Energy Corporation(DVN)

Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said traders were buying calls in Devon Energy Corp (NYSE: DVN) in the first half of the trading session on Thursday.

  • [By Matthew DiLallo]

    While crude prices stumbled into 2016, they found their footing by mid-year and roared back to life, ending the year up about 42%. Those rising prices lifted most oil stocks. However, a handful of large-cap oil stocks rose above the crowd by outperforming crude’s rally. Those top-tier performers wereContinental Resources (NYSE:CLR), Devon Energy (NYSE:DVN), Anadarko Petroleum (NYSE:APC), Pioneer Natural Resources (NYSE:PXD), and Cimarex Energy (NYSE:XEC):

  • [By Paul Ausick]

    Devon Energy Corp. (NYSE: DVN) is rated Hold and the price target was raised to $49. The 2017 EPS estimate was increased from $1.39 to $2.00, and the 2018 estimate increased from $3.06 to $3.83. Shares closed at $43.35 on Friday, in a 52-week range of $21.15 to $50.69. No consensus price target was available.

  • [By Matthew DiLallo]

    U.S. producers hit their peak more than a year ago with production steadily coming down since then due to under-investment. However, the industry has recently started ramping activity back up in an attempt to push back against the natural production decline. For example, leading U.S. driller Devon Energy (NYSE:DVN) reduced its rig count from 40 in early 2015 to five by the third quarter of 2016. As a result, Devon Energy’s third-quarter production from retained assets declined 6.9% year over year. However, Devon Energy has started adding back rigs now that oil prices have stabilized above $50 per barrel and it expected to end 2016 running 10 rigs, with plans to run 15 to 20 by the end of this year. These rigs should push its production up by a low- to mid-single-digitrate this year.

  • [By Ben Levisohn]

    It wasn’t just Marathon that got clipped as the eight worst-performing stocks in the S&P 500 came from the energy sector, including Murphy Oil (MUR), which fell 6.7% to $25.87, Devon Energy (DVN), which slid 6.5% to $40.72, and Chesapeake Energy (CHK), which stumbled 6.1% to $4.94. No surprise, then, that the Energy Select Sector SPDR ETF (XLE) slumped 2.6% to $69.65.

  • [By Matthew DiLallo]

    The failure of Russia and others to fulfill their obligations are coming at a time when U.S. shale production is starting to ramp back up. Shale producers such as Pioneer Natural Resources (NYSE:PXD) and Devon Energy (NYSE:DVN) have already released growth-focused budgets to capture the benefits of an improving oil market. In Pioneer Natural Resources’ case, it expects to spend $2.8 billion this year to operate 18 drilling rigs in the Permian Basin and restart its drilling program in the Eagle Ford. Those rigs should enable the company to drill enough wells to grow its production by 15% to 18% over last year’s average. Meanwhile, Devon Energy expects to spend between $2 billion to $2.3 billion on drilling this year, which should fuel 13% to 17% oil production growth by the fourth quarter versus last year’s final quarter.

Best Medical Stocks To Own Right Now: KLA-Tencor Corporation(KLAC)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    We rate KLA-TENCOR CORP as a Hold with a ratings score of C. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company’s strengths can be seen in multiple areas, such as its increase in net income, notable return on equity and good cash flow from operations. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. 

  • [By Jim Cramer]

    The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Semiconductors & Semiconductor Equipment industry. The net income increased by 45.2% when compared to the same quarter one year prior, rising from $72.23 million to $104.90 million.

     

  • [By JPMorga]

    KLA-Tencor, which is in the process of being acquired by Lam Research, continues to deliver best-in-class dividends as a result of its solid operational performance and strong free cash flow generation. The company’s current dividend yield is at 3.1%. 

  • [By Jim Cramer]

    The debt-to-equity ratio is very high at 10.70 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. Despite the company’s weak debt-to-equity ratio, the company has managed to keep a very strong quick ratio of 3.00, which shows the ability to cover short-term cash needs.

     

Best Medical Stocks To Own Right Now: Uni-Pixel, Inc.(UNXL)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap sensor film stock UniPixel Inc (NASDAQ: UNXL) is sinking by a double digit percentage in after-hours and pre-market trading after reporting Q4 earnings. The problem for UniPixel is that only a few analysts cover the small cap stock and the bottom line loss was a bit worst than the 10 cent loss they were expecting. The stock also had a slight uptick ahead of earnings:

  • [By Peter Graham]

    Small cap sensor film stockUniPixel Inc (NASDAQ: UNXL) reportedQ1 2017 earnings after the Thursday market close withshares falling both on Thursday and in afterhours trading. UniPixel is not well covered or known by analysts yet and this can make shares volatile. However and last September, we had suggested a long position in the stock based upon technicals by saying:

  • [By Lisa Levin]

    Shares of UniPixel Inc (NASDAQ: UNXL) were down 22 percent to $1.63 after the company announced a public offering of newly issued shares of stock. UniPixel plans to offer 5.35 million shares of its own stock at a public offering price of $1.50 per share with the option for its underwriters to purchase up to an additional 802,500 shares.

offshore investments

Vical (NASDAQ:VICL) has been a horror show for investors. Failed trials, poor technology and a lack of awareness have left this small biotech company from San Diego all but forgotten. There are many reasons that a long-term investor would have no interest in this company even though it passes Benjamin Graham’s criteria as a net-net investment because it is trading below cash. I believe there might be one or two more puffs left in this old cigar butt investment if you put a swing trade spin on it.

Although VICL will eventually need to use some of its $43 million in cash to fund operations and trials, we might get a puff or two of profits before it’s gone. With an annual burn rate of $8-11 million the company should be able to advance its pipeline for at least two years with no need to dilute or secure risky financing. This should provide a swing trader with enough time to implement and exit their trade.

VICL’s recent fiduciary responsibility has put it on stable financial footing for the next three years and is what initially caught my interest but not everything is good at VICL. There are some historical and future risks that need to be assessed.

offshore investments: Vanguard Extended Duration Treasury ETF (EDV)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    The 11 ETF fee cuts unveiled by Vanguard include a significant portion of the issuer's fixed income lineup. All of the following saw annual fees reduced to 0.07 percent from 0.1 percent:

    Vanguard Extended Duration Treasury ETF (NYSE: EDV). Vanguard Intermediate-Term Bond ETF (NYSE: BIV). Vanguard Intmdte Tm Govt Bd ETF (NASDAQ: VGIT). Vanguard Long Term Corporate Bond ETF (NASDAQ: VCLT). Vanguard Lg Term Govt Bd ETF (NASDAQ: VGLT). Vanguard Mortgage Bkd Sects ETF (NASDAQ: VMBS).

    and the Vanguard Short Term Corporate Bond ETF (NASDAQ: VCSH).

offshore investments: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

offshore investments: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Fossil is in deep trouble: As mentioned earlier in the week, Fossil (FOSL) came out with more big plans for the smartwatch market at Basel World. Unfortunately, as TheStreet reported, the company is fighting an uphill battle with Apple and could be in big trouble. 

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 25% Wednesday to post a new 52-week low of $13.65 after closing at $18.15 on Tuesday. The stock’s 52-week high is $36.87. Volume was more than 5 times the daily average of around 1.9 million shares. The company missed analysts’ expectations bigly this morning.

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, NVIDIA (NASDAQ:NVDA) and Fossil Group(NASDAQ:FOSL) attracted heavy investor interest following their quarterly earnings reports.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 21% Wednesday, to post a new 52-week low of $18.10 after closing at $22.87 on Tuesday. The stock’s 52-week high is $51.93. Volume was about 15 times the daily average of around 1.2 million shares. The company reported so-so results last night and Wells Fargo cut its rating on the stock to Underperform this morning.

offshore investments: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

offshore investments: Oil States International Inc.(OIS)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Instead, Genargo prefers oil services stocks with the most exposure to the U.S market. Loop names Halliburton Company (NYSE: HAL) as its top large-cap stock pick and Oil States International, Inc. (NYSE: OIS), Newpark Resources Inc (NYSE: NR) and Superior Energy Services, Inc. (NYSE: SPN) as its top small- and mid-cap stocks.

  • [By Michael J. Carr]

    Einhorn selects investments with a traditional value approach, although he may not be as patient as a typical value investor. Einhorn took Apple (Nasdaq: AAPL) to court in an effort to force the company to return cash to shareholders, and more recently challenged Oil States International (NYSE: OIS) to unlock shareholder value.

offshore investments: CareDx, Inc.(CDNA)

Advisors’ Opinion:

  • [By Lisa Levin]

    CareDx Inc (NASDAQ: CDNA) was down, falling around 25 percent to $1.61 after the company reported weak preliminary sales for fourth quarter and FY 2016.

Top 5 Low Price Stocks To Buy Right Now

A few days ago, an article about Nike (NYSE:NKE) argued that “Nike’s shares aren’t priced to buy.” The reasoning was that “Nike is, at best, fairly valued. And it certainly isn’t trading hands at fire-sale prices.” The question is: should you expect (and wait for) fire-sales prices? Most value investors know the maxim that it is better to buy a great business at a fair price than to buy a mediocre business at low price. We think that Nike is a great business at a fair price. We have been waiting for Nike’s price to come down for a long time and meanwhile, we have sold PUT options, though unfortunately these options have never been exercised (but we cashed-in premiums). Today, we bought the stock.

Reasons to avoid the stock

We invest with a long-term view and therefore we ask long-term questions:

Has the management of Nike changed its strategy? Is Nike’s long-term strategy ultimately going to fail? Is there anything that can or has damaged the Nike brand?

Of course, competition is there, but is there any industry where there is no long-term competition? Under Armour (NYSE:UAA), Adidas (OTCQX:ADDDF), Lululemon (NASDAQ:LULU) are all good companies, but they have always been there. Under Armour and Lululemon are perceived as new entrants, but they were actually founded 20 years ago (in 1996 and 1998), Adidas is almost a century old, while Nike is “only” 52-years old. So, what has changed? These industries move in waves, but the quality of the Nike brand, its management, and innovation have been a constant. In sum, if your answer to any of the previous questions is YES, then you should reconsider our investment thesis. If it is NO, then we can move on to the next paragraph.

Top 5 Low Price Stocks To Buy Right Now: Charter Communications, Inc.(CHTR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of OBERNDORF WILLIAM E’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=OBERNDORF+WILLIAM+E

    These are the top 5 holdings of OBERNDORF WILLIAM EWorkiva Inc (WK) – 2,369,384 shares, 43.81% of the total portfolio. Shares added by 38.81%AppFolio Inc (APPF) – 839,797 shares, 26.98% of the total portfolio. Shares reduced by 39.22%Liberty Global PLC (LBTYK) – 289,812 shares, 12% of the total portfolio. Herbalife Ltd (HLF) – 145,000 shares, 9.96% of the total portfolio. Charter Communications Inc (CHTR) – 18,758 shares, 7.25% of the total portfolio.

  • [By Adam Levy]

    Image source: Getty Images.

    It was just a little more than a year ago when Comcast (NASDAQ:CMCSA) was the largest U.S. pay-TV provider. And it wasn’t even close. But after AT&T (NYSE:T) merged with DirecTV, it took over the top spot. Now, AT&T’s rival telecom company, Verizon (NYSE:VZ), is reportedly considering a megamerger of its own with Charter Communications (NASDAQ:CHTR). The move would put the combined company’s total video subscriber count very close to Comcast’s.

    The potential merger points to a big hole in Comcast’s service offerings — its lack of wireless service. If customers can save money by bundling their TV, internet, and wireless bills together with its competitors, Comcast stands to lose customers. But Comcast’s management and investors shouldn’t lose sleep over the possibility that its two biggest competitors offer wireless service.

  • [By Matt Hogan]

    It has been widely reported that T-Mobile US Inc. (NASDAQ: TMUS) had been in merger talks with Sprint Corp. (NYSE: S), a competitor that is majority owned by Softbank. However, these talks are now on hold as Sprint is negotiating potential deals with two of the largest cable companies in the United States; Comcast Corporation (NASDAQ: CMCSA) and Charter Communications, Inc. (NASDAQ: CHTR). These cable companies are under pressure having lost subscribers due to services like Netflix, Inc. (NASDAQ: NFLX), which recently blew away its second quarter growth estimates.

  • [By Money Morning Staff Reports]

    SoftBank also purchased telecom upstart Sprint Corp. (NYSE: S) in 2013. And it is considering deals with other communications giants, including Charter Communications Inc. (Nasdaq: CHTR) and T-Mobile U.S. Inc. (Nasdaq: TMUS)

Top 5 Low Price Stocks To Buy Right Now: NXP Semiconductors N.V.(NXPI)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    While Qualcomm continues to work on closing its $47 billion acquisition of automotive chipmaker NXP Semiconductor (NSDQ:NXPI), at the CES 2017, NXP showcased why the company is a major force in automotive computing.At the show, NXP partnered with several companies to demonstrate a “collective vision of safe and secure end-to-end mobility through a highly automated driving demonstration and experience.” NXP also demonstratedits so-called RoadLINK platform in collaboration with automotive parts giant Delphiand privately held start-up Savari, highlighting the traffic safety improvements one can achieve through the platform.

  • [By Sreekanth Anasa]

    Qualcomm may be haunted by its legal woes but there are a lot of positive developments for the chipmaker as well. The demand for Qualcomm’s latest flagship offering Snapdragon 835 is exceeding supply. Though the difference is caused by supply and manufacturing limitations it bodes well for the San Diego chip giant as it suggests healthy demand for its high-end chips amid sluggish smartphone sales worldwide. The company is also expected to win more market share among Chines OEMs in 2H17 particularly withOppo and Vivo.Jun Zhang ofRosenblatt Securities states that “Qualcomms market share in China to grow from 50% in 2016 to 65% in 2017 with share gains in OPPO, Vivo, Xiaomi and Meizu, with stable market share in Samsung. We also believe Chinese OEMs will adopt the Snapdragon 835 in late-Q2 or early Q3.” However, analysts are afraid that all these may not offset the losses caused by the legal face-off with Apple. The next major catalyst for QCOM would be the impending acquisition of NXP Semiconductor (NASDAQ:NXPI).Steve Mollenkopf, CEO of Qualcomm, reiterated that the acquisition is on track during the earnings call and spent considerable time discussinglarger growth opportunitiesthat will be unlocked by the conclusion of this acquisition.

  • [By Anders Bylund]

    NXP Semiconductors (NASDAQ:NXPI) is closing out 2016 with a 16% return for the full year. Here’s what to expect out of the Netherlands-based embedded chip maker in 2017.

  • [By Anders Bylund]

    So NXP Semiconductors (NASDAQ:NXPI) is waiting for the final regulatory approvals to trigger an avalanche of shares being committed to Qualcomm ‘s (NASDAQ:QCOM) long-running tender offer. The pending buyout may have frozen NXP’s stock prices just below Qualcomm’s firm all-cash offer of $110 per share, but NXP isn’t sitting on its hands while the merger drama plays out.

  • [By Sreekanth Anasa]

    Qualcomm stock has continued rise steadilyeven after the initialpop on account of the news of Broadcom’s multi-billion dollar acquisition offer. Investors were waiting for further gains from this catalyst as experts and the markets were hoping for the Irvine, California-based semiconductor giant to soon come up with an increased offer with the initial offer being rejected. The new bid was expected to come next week when a proposal to replace the current set of Qualcomm board directors is to be tabled. Now, if one goes by the latest reports, it seems thatBroadcom isn’t planning to propose a new increased bid until sometime closer to Qualcomms board meeting in March. This is a good three months away. Qualcomm’s bid to close the NXP Semiconductor (NASDAQ:NXPI) acquisition is also acting as a roadblock for Broadcom to table an increased offer. Reports state that Broadcom could also likely wait till the regulatory bodies give a green signal to the NXP deal which again as per both the companies involved is likely to see a closure only sometime early next year.

Top 5 Low Price Stocks To Buy Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

Top 5 Low Price Stocks To Buy Right Now: Carnival Corporation(CUK)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Carnival Corporation & plc (NYSE:CCL) (NYSE:CUK)shareholders have to be feeling pretty good these days. The stock hit yet another new high on Friday, and the stock is trading 13% higher so far in 2017.It’s been smooth sailing so far this year, but the first big test comes on Tuesday morning when the world’s largest cruise line operator reports financial results for its fiscal first quarter.

Top 5 Low Price Stocks To Buy Right Now: Pacific Ethanol Inc.(PEIX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Pacific Ethanol Inc (NASDAQ: PEIX) got a boost, shooting up 30 percent to $5.47 after the company reported stronger-than-expected earnings for its fourth quarter.

stock market games

Originally published on Finbox.io.

The next iteration of the iPhone will also be the 10 year anniversary of Apple Inc. (NASDAQ: AAPL)'s first highly successful iPhone. The iPhone now contributes close to two-thirds of Apple's total revenue. In order to meet investor and consumer anticipation, Apple needs to deliver improved functionalities with the new iPhone 8. And as a result, the company's bill of materials (or BOM) will likely get pushed significantly higher.

This is not entirely surprising in an increasingly competitive market. Even the Samsung S8 recently saw a 16 percent increase in BOM (from $264.16 to $307.50) compared to its S7. Last year, the which was 20% higher than the iPhone 6S' BOM.

 

However, Apple now has less leverage when trying to pass through its component costs to the end consumer due to a more competitive market – specifically in China. So simply increasing the average selling price (or ASP) may no longer be an option for Apple.

But how much will the iPhone 8's BOM really increase?

iPhone 8's Expected Cost Increase

When looking at component prices, UBS recently estimated that the bill of materials for the iPhone 8 is going to be substantially higher than last year.

stock market games: Novo Nordisk A/S(NVO)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

  • [By Paul Ausick]

    Novo Nordisk A/S (NYSE: NVO) dropped about 1.5% on Friday to post a new 52-week low of $32.35 after closing at $32.84 on Thursday. The stock’s 52-week high is $59.00. Volume of about 3.4 million was close to the daily average of around 3.9 million shares. The drug maker had no specific news.

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Brian Orelli]

    Global Blood Therapeutics (NASDAQ:GBT) is up 20% at 3:42 p.m. EST after Reuters reported that Novo Nordisk (NYSE:NVO) has approached the biotech about a potential acquisition.

  • [By Keith Speights]

    Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY) fit that description well. Each of these companies markets obesity drugs, but each also sells a broad array of other products with multiple pipeline candidates potentially on the way. Here’s why Eisai, Novo Nordisk, and Roche rank as the three best obesity-drug stocks to buy in 2017.

stock market games: Laredo Petroleum, Inc.(LPI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After a rally for the ages, the price of oil is back over $50. But the biggest threat to oil might be more production from exploration & production companies drilling in the U.S. shale, say Credit Suisse analyst Mark Lear and team, who cut their ratings on Carrizo Oil & Gas (CRZO), Laredo Petroleum (LPI) and Sanchez Energy (SN). They explain why:

stock market games: Coach, Inc.(COH)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    Fashion is already a tough play on the stock market. Once-popular labels likeMichael Kors(NYSE:KORS) andCoach(NYSE:COH) have tumbled recently as their brands seem to have become diluted in a highly competitive handbag market. The problem with investing in stocks like these is that often what’s in style one year is on the discount rack just a few years later.

  • [By Ben Levisohn]

    Kate Spade (KATE) caught a bounce on Wednesday when the Wall Street Journalreported that it was actively seeking a buyer. Since then, we’ve learned that the fashion accessories retailer looks set to auction itself off to the highest bidder, with the process potentially beginning next month, with bidders potentially including Coach (COH) and Michael Kors (KORS). In a note today, SunTrust Robinson Humphrey analystPamela Quintiliano and team contend that Kate Spade could fetch as much as $23 a share:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By Ben Levisohn]

    Coach (COH) has risen 1.1% to $37.76 after getting upgraded to Buy from Hold at Evercore ISI.

    Illumina (ILMN) has dropped 2.4% to $156.22 after beating fourth-quarter earnings forecasts but offering first-quarter revenue guidance that fell short of analyst expectations.

stock market games: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

stock market games: American Superconductor Corporation(AMSC)

Advisors’ Opinion:

  • [By William Romov]

    According to S&P Capital IQ, shares of TTOO have an average price target of $5.75, representing 40.24% upside from current levels.

    Penny Stocks to Buy for December 2017, No. 4: American Superconductor Corp. (Nasdaq: AMSC)

    Massachusetts-based American Superconductor Corp. (Nasdaq: AMSC) makes two-megawatt wind turbines under the Windtec Solutions brand. The company also sells products and services to connect electricity-generating equipment with the power grid.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to

stock market games: Crescent Point Energy Corp (16)

Advisors’ Opinion:

  • [By Kana Nishizawa]

    China Coal Energy Co., the countrys second-largest producer of the fuel, sank 3.1 percent after the government said it will cut coal consumption. Sun Hung Kai Properties Ltd. (16), the worlds second-biggest developer, fell 1.4 percent after trimming its sales target. Gold producers led materials companies lower as the precious metal headed for its steepest weekly loss since June amid expectations the U.S. Federal Open Market Committee will next week decide to reduce stimulus.

Top 5 Gold Stocks To Invest In 2018

Forget about boring stocks. Bitcoin is where it’s at these days for investors.

The virtual currency is now trading at a record high above $8,200 — just a little more than a month after bitcoin first passed the $5,000 level. If this keeps up, bitcoin could be trading at $10,000 before the end of the year.

The price of one bitcoin (XBT) has surged more than 735% this year alone and has skyrocketed nearly 40,000% in the past five years.

Of course, bitcoin’s meteoric rise has led to some skepticism. JPMorgan Chase (JPM) CEO Jamie Dimon has bashed it on numerous occasions, calling it a “fraud” that’s better off being used by drug dealers and North Korea.

And Saudi Prince Alwaleed, a billionaire whose Kingdom Holding Company owns stakes in Apple (AAPL, Tech30) and Citigroup (C), told CNBC before he was arrested in a sweeping anti-corruption probe that he thought bitcoin was an “Enron in the making” that will implode.

But while some see a bubble about to burst, others see opportunity. Lloyd Blankfein, the CEO of JPMorgan Chase rival Goldman Sachs (GS), took issue with bitcoin critics.

Top 5 Gold Stocks To Invest In 2018: Brookfield Renewable Powerr Fund(BEP)

Advisors’ Opinion:

  • [By Federico Zaldua]

    I expect the Brookfield Group of Companies, which is composed of no fewer than 15 publicly traded entities, to be very active acquisitive in the near-term future. Here I focus my attention on three members of the Brookfield Group that are going to be the most active with M&A. While Brookfield Asset Management (BAM) will concentrate its M&A efforts into all geographies and all asset classes, Brookfield Renewable Energy Partners (BEP) and Brookfield Infrastructure Partners (BIP) will concentrate on their respective industries. Let’s see whether you should go long on any of this separate -although related – entities.

    Good Operational Performance

    Brookfield Asset Management, held by Lou Simpson and Ron Baron, counts with a liquidity position of more than $5 billion at the parent and principal subsidiaries along with nearly $10 billion drawable private fund commitments. More importantly, the company has expressed its interest into using this liquidity to make acquisitions. Management clearly stated in its letter to shareholders:

Top 5 Gold Stocks To Invest In 2018: Grifols, S.A.(GRFS)

Advisors’ Opinion:

  • [By Monica Wolfe]

    Grifols SA (GRFS)

    Paulsons fourth largest holding is in Grifols SA where he holds on to 19,786,279 shares of the companys stock. His position in the company represents 4% of his total portfolio and 5.76% of the companys shares outstanding.

Top 5 Gold Stocks To Invest In 2018: CF Industries Holdings, Inc.(CF)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.63 percent. Meanwhile, top losers in the sector included Myers Industries, Inc. (NYSE: MYE), down 7 percent, and CF Industries Holdings, Inc. (NYSE: CF) down 6 percent.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was CF Industries Holdings, Inc. (NYSE: CF) which jumped 3.7% to $30.37. The stocks 52-week range is $20.77 to $37.17. Volume was 5.3 million which is just under the daily average of around 5.4 million shares.

  • [By Ben Levisohn]

    CF Industries Holdings (CF) has climbed 3.3% to $30.25 after getting upgraded to Buy from Neutral at Goldman Sachs.

    Nektar Therapeutics (NKTR) has soared 21% to $18.80 after positive results from a pain-killer trial.

  • [By Ben Levisohn]

    CF Industries (CF) rose to the top of the S&P 500 today, continuing strength that began earlier this month.

    Getty Images

    CF Industries gained 6.9% to $28.96 today, while the S&P 500 fell 0.2% to 2,181.90. CF Industries has gained 21% in November.

    Despite the rally, CF Industries is still down 29% this year, and as recently as Nov.3, Citigroup’s P.J. Juvekar and team were writing that the fertilizer company was “looking more like a 2008 story” after weaker-than-expected earnings. Donald Trump’s election victory, however, has jumpstarted CF Industries and prompted FBN technical analystJC OHara to list it among the top-50 stocks following Trump’s election, noting that “we want to own the stocks that were first to leave the gate…New Momentum should continue.” On Nov. 9, Barron’s Michael Kahn agreed, writing that “CF Industries does merit a look.”

    CF Industries reported net income of $700 million on sales of $4.3 billion in 2015. Its market capitalization rose to $6.8 billion today from $6.3 billion yesterday.

     

Top 5 Gold Stocks To Invest In 2018: Exterran Corporation(EXTN)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Company Name

    Share PriceYTDMarket CapClayton Williams Energy Inc. (NYSE: CWEI)$138.8216.4%2.4BDiamondback Energy Inc. (Nasdaq: FANG)$106.365.42%$9.38BWestern Gas Partners LP (NYSE: WES)$65.6411.71%$9.67BTesoro Logistics LP (NYSE: TLLP)$59.3416.79%$6.25BResolute Energy Corp. (NYSE: REN)$46.0811.87%$931.13MAntero Midstream Partners LP (NYSE: AM)$34.9813.28%$6.4BExterran Corp. (NYSE: EXTN)$33.9942.22%$1.19BDominion Midstream Partners LP (NYSE: DM)$32.9011.34%$2.6BNextEra Energy Partners LP (NYSE: NEP)$31.1922.12%$1.68BArchrock Inc. (NYSE: AROC)$16.0021.21%$1.12B

    While some of these stocks have performed well, we arent recommending this list of natural gas stocks. Thats because we arent interested in stocks that have already peaked at Money Morning; were interested in the next big winner. And we have one that could surge in 2017

Top 5 Gold Stocks To Invest In 2018: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

stock dividend

For many years, NVIDIA (NASDAQ:NVDA) has relied on Taiwan Semiconductor Manufacturing Company (NYSE:TSM) to manufacture the graphics chips it designs. Today, most of NVIDIA’s Pascal architecture-based graphics processors — from the GeForce GTX 1060, designed for mainstream PC gamers, all the way through its cutting edge Tesla P100 datacenter accelerators — are manufactured by TSMC.

What’s interesting, though, is that the company’s entry-level gaming processor — a chip known as GP107, and sold as the GeForce GTX 1050 and GeForce GTX 1050 Ti — isn’t built by TSMC. Instead, it’s built by Samsung (NASDAQOTH:SSNLF) on that company’s 14-nanometer LPP technology.

Image source: NVIDIA.

However, whileNVIDIA is sourcing mass-market graphics chips from a rival, it appears that its relationship withTaiwan Semiconductoris deepening rather than degrading. Here are some reasons to think so.

stock dividend: Kona Grill Inc.(KONA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Kona Grill Inc (NASDAQ: KONA) was down, falling around 25 percent to $2.00 after the company reported downbeat quarterly results.

    Commodities

stock dividend: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

stock dividend: SL Green Realty Corporation(SLG)

Advisors’ Opinion:

  • [By Nelson Hem]

    “Manhattan on Sale? That’s the Case With Two Cheap REITS” by Andrew Bary discusses whether Manhattan-focused real estate investment trusts Vornado Realty Trust (NYSE: VNO) and SL Green Realty Corp (NYSE: SLG) could rally as the New York market firms. Both trade at a discount to the value of private-market property deals, says the article.

stock dividend: NXP Semiconductors N.V.(NXPI)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    The acquisition of NXP Semiconductor (NSDQ:NXPI) has opened up multi-billion dollar connected devices market from smartphone to car to home, for Qualcomm. It seems prepared to cater to the massive connected devices market in terms of OS preference with Android and Windows 10 mobile collaborations. Though Amazon and its AWS have different take on cloud and IoT devices with its Greengrass solution which revolves around the cloud and aggregation of sensors.

  • [By Sreekanth Anasa]

    EvenCanaccords T. Michael Walkleyis also of a similar view and reiterated a buy rating on QCOM stock recently. Mr.Walkley opines that the litigation against the smartphone chipmaker is motivated by Apple’s(NASDAQ:AAPL) intention to lower its license payments. He has a price target of $76 on QCOM stock and still considers Qualcomm an attractive long-term investment. According to him, the growing royalty fees collection from ChineseOEMs and the impending NXP Semiconductor (NASDAQ: NXPI) acquisition, which is on track as per him, are the long-term growth drivers for QCOM stock.

  • [By Sreekanth Anasa]

    Qualcomm may be haunted by its legal woes but there are a lot of positive developments for the chipmaker as well. The demand for Qualcomm’s latest flagship offering Snapdragon 835 is exceeding supply. Though the difference is caused by supply and manufacturing limitations it bodes well for the San Diego chip giant as it suggests healthy demand for its high-end chips amid sluggish smartphone sales worldwide. The company is also expected to win more market share among Chines OEMs in 2H17 particularly withOppo and Vivo.Jun Zhang ofRosenblatt Securities states that “Qualcomms market share in China to grow from 50% in 2016 to 65% in 2017 with share gains in OPPO, Vivo, Xiaomi and Meizu, with stable market share in Samsung. We also believe Chinese OEMs will adopt the Snapdragon 835 in late-Q2 or early Q3.” However, analysts are afraid that all these may not offset the losses caused by the legal face-off with Apple. The next major catalyst for QCOM would be the impending acquisition of NXP Semiconductor (NASDAQ:NXPI).Steve Mollenkopf, CEO of Qualcomm, reiterated that the acquisition is on track during the earnings call and spent considerable time discussinglarger growth opportunitiesthat will be unlocked by the conclusion of this acquisition.

stock dividend: Tenneco Inc.(TEN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of auto-part makers like Delphi Automotive (DLPH), BorgWarner (BWA), and Tenneco (TEN) are getting killed today, ostensibly due to an article in Automotive News. Wells Fargo’s Richard Kwas and team think Tesla Motors (TSLA) and its Model 3 deserve at least some of the blame:

stock dividend: SPX Corporation(SPW)

Advisors’ Opinion:

  • [By Damon Churchwell]

    These companies manufacture processing products used by industries such as food and beverages, oil & gas, and wastewater treatment, among others. They serve a wide range of end markets that are mostly poised for increased earnings and are likely to spend on capital projects. While these positive trends persist, flow technology companies’ prospects ought to remain favorable. Let’shighlight several sector participants, starting with a top selection,SPX(NYSE: SPW),.

Top 10 Clean Energy Stocks To Buy Right Now

It’s no secret: Traditional cable networks like Viacom, Inc. (NASDAQ:VIAB) and Time Warner Inc (NYSE:TWX) have had their backs planted firmly against the wall thanks to the rising popularity in streaming content from companies like Netflix, Inc. (NASDAQ:NFLX).

But a recent report from Bernstein may have added another layer of support to the bullish NFLX stock story, while digging the knife deeper into traditional networks.

The primary finding from the report?

The average viewership in children’s networks, by children, has declined 50% over the past six years “and it’s still declining at high-teens rates.”

A Small Victory for Netflix Stock in a Much Bigger War?

As the report notes, the fact that children’s television viewership has been declining is not in itself a newsworthy revelation, but the massive 50% decline is. Especially, when you consider how damaging it is to big-time networks like Viacom:

Top 10 Clean Energy Stocks To Buy Right Now: Bank of the Ozarks(OZRK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Bank Of The Ozarks Inc (NASDAQ: OZRK) reported better-than-expected earnings for its second quarter on Monday.

    Bank of the Ozarks disclosed net income of $54.5 million for the second quarter compared to $44.8 million representing an increase of 21.7 percent. On a per share basis, earnings grew 17.6 percent to $0.60 from $0.51 in the year-ago quarter. This was higher by a penny from the Street analysts' expectations.

Top 10 Clean Energy Stocks To Buy Right Now: Inter Parfums, Inc.(IPAR)

Advisors’ Opinion:

  • [By Monica Gerson]

    Inter Parfums, Inc. (NASDAQ: IPAR) is estimated to post its quarterly earnings at $0.31 per share on revenue of $110.58 million.

    Norwegian Cruise Line Holdings Ltd (NASDAQ: NCLH) is expected to report its quarterly earnings at $0.37 per share on revenue of $1.10 billion.

Top 10 Clean Energy Stocks To Buy Right Now: Estee Lauder Companies, Inc. (The)(EL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The 20 stocks meeting those requirements are: Ralph Lauren (RL), Time Warner(TWX), Twenty-First Century Fox(FOXA), PepsiCo(PEP), Estee Lauder(EL), Tesoro(TSO), XL(XL), Ameriprise Financial,(AMP), Unum(UNM), Merck(MRK), AbbVie(ABBV), Gilead Sciences(GILD), General Dynamics(GD), Alaska Air(ALK), United Continental(UAL), Delta Air Lines(DAL), Oracle(ORCL), eBay(EBAY), Apple(AAPL), and Centurylink(CTL).

  • [By WWW.THESTREET.COM]

    GLP’s customers include Walmart (WMT) , Unilever (UL) , JD.com (JD) , Adidas (ADDYY) , Estee Lauder (EL) and L’Oreal (LRLCY) .

    The S$3.38 offer price represents 81% premium over its 12-month volume weighted average price and a 25% premium over its last full trading day before the announcement.

Top 10 Clean Energy Stocks To Buy Right Now: Natera, Inc.(NTRA)

Advisors’ Opinion:

  • [By Cory Renauer]

    Shares of Natera Inc. (NASDAQ:NTRA), a leader in non-invasive DNA analysis, finished Wednesday’s session 17.6% higher following Tuesday afternoon’s earnings call. Strong uptake across the board gave investors a reason to cheer.

Top 10 Clean Energy Stocks To Buy Right Now: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

Top 10 Clean Energy Stocks To Buy Right Now: Cray Inc(CRAY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the technology sector proved to be a source of strength for the market. Leading the sector was strength from Cray Inc. (NASDAQ: CRAY) and Mellanox Technologies, Ltd. (NASDAQ: MLNX).

  • [By Giulio Prisco]

    Microsoft (NSDQ:MSFT), supercomputer maker Cray (NSDQ:CRAY), and the Swiss National Supercomputing Centre (CSCS), a world-class scientific computing center, announced the results of a deep learning collaboration that expands the horizons of running Artificial Intelligence (AI), Machine Learning (ML), and in particular Deep Learning (an especially promising branch of ML) applications, using Microsoft software and Cray supercomputers.

  • [By Jim Robertson]

    Cray Inc. (CRAY) has been one of those feast or famine small caps that have either made traders and investors a lot of money in recent years – or simply frustrated those who’ve held it for quite some time. However, at this point we think CRAY offers an attractive risk/reward opportunity on a long-term basis for investors interested in exposure to big data analytics and specifically super-computing – a growing need for large enterprise and institutions all over the world

Top 10 Clean Energy Stocks To Buy Right Now: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Jim Robertson]

    Last Friday, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical stock Forward Pharma A/S (NASDAQ: FWP):

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

Top 10 Clean Energy Stocks To Buy Right Now: Dupont Fabros Technology, Inc.(DFT)

Advisors’ Opinion:

  • [By Lisa Levin]

    DuPont Fabros Technology, Inc. (NYSE: DFT) shares shot up 10 percent to $61.07. Digital Realty Trust, Inc. (NYSE: DLR) announced plans to merge with DuPont Fabros.

Top 10 Clean Energy Stocks To Buy Right Now: RetailMeNot, Inc.(SALE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of RetailMeNot Inc (NASDAQ: SALE) got a boost, shooting up 12 percent to $8.42. RetailMeNot announced after Thursday’s close it has entered into an agreement to acquire GiftCard Zen, a secondary marketplace for gift cards. The company reported preliminary Q1 revenue of $54 million to $54.5 million and FY16 revenue of $228 million to $241 million.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, RetailMeNot (NASDAQ:SALE) and SUPERVALU (NYSE:SVU) attracted heavy investor interest following merger and acquisition news.

Top 10 Clean Energy Stocks To Buy Right Now: Fastenal Company(FAST)

Advisors’ Opinion:

  • [By Monica Gerson]

    Breaking news

    Shares of Alcoa Inc (NYSE: AA) dropped over 7 percent in pre-market trading after the company reported Q3 results. Alcoa posted Q3 adjusted earnings of $0.32 per share on sales of $5.2 billion.
    Fastenal Company (NASDAQ: FAST) released third quarter financial results, reporting an earnings miss while revenue came in line with Street estimates. To read the full news, click here.
    Twilio Inc (NYSE: TWLO) announced preliminary results for the third quarter that came in above the Street estimates. To read the full news, click here.
    According to the Associated Press, Samsung Electronics (OTC: SSNLF) said it will no longer manufacturer its Galaxy Note 7 smartphones. The permanent discontinuation follows a round of reports saying customer's replacement phones have caught fire. To read the full news, click here.

  • [By Monica Gerson]

    Fastenal Company (NASDAQ: FAST) is estimated to report its quarterly earnings at $0.45 per share on revenue of $988.60 million.

    Perry Ellis International, Inc. (NASDAQ: PERY) is projected to report its quarterly earnings at $0.35 per share on revenue of $214.26 million.

online options trading

Today, we’re giving you our bold new oil price prediction now that OPEC renewed its production cut agreement for nine more months. We’re expecting double-digit gains for oil prices in the next three months…

Precise details of OPEC’s production cut haven’t been made public yet, but The Wall Street Journal is reporting OPEC members agreed to extend their 1.2 million barrels per day production cut deal until March 2018. That would cut off about 2% of the world’s oil supply over the remaining nine months of the agreement.

By reducing the world’s oil supply, OPEC expects oil prices will rise as long as demand stays the same or continues to grow.

online options trading: Euro FX(P)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    The long saga regarding Pandora Media Inc. (NYSE: P) has finally come to a head. Well, maybe. Rather than KKR & Co. L.P. (NYSE: KKR) investing $150 million, Sirius XM Holdings Inc. (NASDAQ: SIRI) will be investing up to $480 million in the streaming music rival. With its ticketing unit sale taking place as well, it might seem that Pandora is getting a great deal and helping to bolster its books.

  • [By Paul Ausick]

    Pandora Media Inc. (NYSE: P) dropped about 3.8% Monday to post a new 52-week low of $6.76 after closing at $7.03 on Friday. The stock’s 52-week high is $14.98. Volume of nearly 15 million was about 15% below the daily average. The company had no specific news.

  • [By Rick Munarriz]

    One can argue that the boo birds have a lot of fair reasons to be bearish. The stock is at its highest point in more than a decade, prompting valuation concerns. The company continues to court Pandora (NYSE:P) in public, a potential purchase that the market generally isn’t very excited about. There’s also the incessant fear that the smartphone revolution and the connected car will dismiss satellite radio as transitory and expensive entertainment.

  • [By Paul Ausick]

    Pandora Media Inc. (NYSE: P) reported second-quarter results after markets closed Monday. For the quarter, the Internet radio company posted an adjusted diluted net loss per share of $0.21 on revenues of $376.83 million. In the same period a year ago, the company reported a net loss of $0.12 on revenues of $343.02 million. Second-quarter results compare to the consensus estimate for a net loss of $0.24 on $368.87 million in revenues.

online options trading: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

online options trading: Toll Brothers Inc.(TOL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Next, on Tuesday, earnings from Darden Restaurants (DRI) and KB Home (KBH) . Cramer said he liked both companies, but prefers Toll Brothers (TOL) among the homebuilders.

  • [By Dan Caplinger]

    The stock market once again proved its resiliency on Wednesday, bouncing back from extensive declines early in the session to recover most of its losses. The Dow Jones Industrials actually managed to post yet another record close with a modest gain, and although other major market benchmarks suffered declines, they weren’t significant. Moreover, some favorable news from certain pockets of the market helped bolster investor confidence. Toll Brothers (NYSE:TOL), Lantheus Holdings (NASDAQ:LNTH), and Norwegian Cruise Line Holdings (NASDAQ:NCLH) were among the top performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Eileen Rojas]

    Toll Brothers has rising sales volume and unit prices
    For the third quarter ended on July 31, Toll Brothers’ (NYSE: TOL  ) net income was $46.6 million, or $0.26 per share. The latest income figures were down 24% from last year’s third-quarter results of $61.6 million, or $0.36 per share. The company’s total quarterly revenues were $689.2 million, up 24% over last year, and homebuilding deliveries were 1,059 units, up 10% compared to the same period last year.

  • [By Lisa Levin]

    Toll Brothers Inc (NYSE: TOL) reported stronger-than-expected profit for its third quarter, while revenue missed estimates

    Toll Brothers posted quarterly earnings of $0.87 per share on revenue of $1.502 billion. However, analysts were expecting earnings of $0.69 per share on revenue of $1.51 billion.

  • [By George Putnam, Editor, New Generation Research, Inc.]

    Steve Halpern: Now, another company that you talk about is Toll Brothers (TOL), which focuses on the higher-end of the home market, as well as condominiums. Do you think there’s still opportunity with TOL?

online options trading: Gol Linhas Aereas Inteligentes S.A.(GOL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Gol Linhas Aereas Inteligentes SA (ADR) (NYSE: GOL) is expected to post a quarterly loss at $0.73 per share on revenue of $705.31 million.

    Caretrust REIT Inc (NASDAQ: CTRE) is estimated to post its quarterly earnings at $0.26 per share on revenue of $22.21 million.

  • [By Dan Caplinger]

    Yet some stocks didn’t participate in the rally, instead contending with negative news of their own. Zoe’s Kitchen (NYSE:ZOES), GOL Lineas Aereas Inteligentes (NYSE:GOL), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    Regional Airlines: The industry dropped 1.9 percent by 11:00 am. The worst performer in this industry was Gol Linhas Aereas Inteligentes SA (ADR) (NYSE: GOL), which declined 5.8 percent.

online options trading: Lockheed Martin Corporation(LMT)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Lockheed Martin Corp.’s (NYSE: LMT) market capitalization is the largest of any defense company – anywhere.

    Lockheed Martin performs research, development, and manufacturing for products in security, defense, and technology.

  • [By Money Morning News Team]

    Lockheed Martin Corp. (NYSE: LMT) is the largest defense company on the planet as measured in market capitalization. It’s our No. 1 pick out of our top picks for several reasons. One is the breadth of its products and reach. It develops and manufactures security, defense, and technology products worldwide.

  • [By Elizabeth Balboa]

    In 2015, the government contracted Lockheed Martin Corporation (NYSE: LMT) for services totaling $36.7 billion. That same year, Lockheed Martin’s operating costs were $36.26 billion.

  • [By A.J. Bursick]

    For example, Bill recommended Lockheed Martin Corp. (NYSE: LMT) in November 2013. He noted the varying projects that LMT was involved with, including the construction of U.S. spy planes and the U.S. Department of Defense’s construction of its THAAD anti-missile defense system.

  • [By Ben Levisohn]

    Donald Trump has added a level risk for stock pickers that didn’t exist before his election: The random tweet. Lockheed Martin (LMT) and its price F-35 fighter jet have been a target of his ire, as well as high drug prices. Now he’s turning his attention to General Motors (GM), which sold off earlier this morning after Trump tweeted that the U.S. automaker should produce its Chevy Cruze in the U.S. or pay the price. Shares of General Motors, however, have rallied back into positive territory this afternoon. CFRA Research’s Efraim Levy explains why: